Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Joseph

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Infection and Immunity|January 27, 2004
Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigensSarah Joseph, Frances M Jones, Gachuhi Kimani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and genderMark Booth, Joseph K Mwatha, Sarah Joseph, et al.
Journal of Medicinal Chemistry|January 4, 2022
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding SiteZhiqing Liu, Yi Li, Haiying Chen, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Changes in Cerebrospinal Fluid Proteins across the Spectrum of Untreated and Treated Chronic HIV-1 InfectionZicheng Hu, Paola Cinque, Ameet Dravid, et al.
International Archives of Allergy and Immunology|October 5, 2006
Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposureColin M Fitzsimmons, Rowena McBeath, Sarah Joseph, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
The Journal of Infectious Diseases|April 16, 2003
Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparumCynthia W A Naus, Frances M Jones, Mohamed Z Satti, et al.
The Journal of Infectious Diseases|July 24, 2004
Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantelSarah Joseph, Frances M Jones, Klaudia Walter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 20, 2005
Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, UgandaDavid W Dunne, Birgitte J Vennervald, Mark Booth, et al.
Human Vaccines & Immunotherapeutics|August 8, 2023
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiencesJonathan Kitonsa, Onesmus Kamacooko, Eugene Ruzagira, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Infection and Immunity|January 27, 2004
Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigensSarah Joseph, Frances M Jones, Gachuhi Kimani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and genderMark Booth, Joseph K Mwatha, Sarah Joseph, et al.
Journal of Medicinal Chemistry|January 4, 2022
Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding SiteZhiqing Liu, Yi Li, Haiying Chen, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Changes in Cerebrospinal Fluid Proteins across the Spectrum of Untreated and Treated Chronic HIV-1 InfectionZicheng Hu, Paola Cinque, Ameet Dravid, et al.
International Archives of Allergy and Immunology|October 5, 2006
Factors affecting human IgE and IgG responses to allergen-like Schistosoma mansoni antigens: Molecular structure and patterns of in vivo exposureColin M Fitzsimmons, Rowena McBeath, Sarah Joseph, et al.
Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.
The Journal of Infectious Diseases|April 16, 2003
Serological responses among individuals in areas where both schistosomiasis and malaria are endemic: cross-reactivity between Schistosoma mansoni and Plasmodium falciparumCynthia W A Naus, Frances M Jones, Mohamed Z Satti, et al.
The Journal of Infectious Diseases|July 24, 2004
Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantelSarah Joseph, Frances M Jones, Klaudia Walter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 20, 2005
Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, UgandaDavid W Dunne, Birgitte J Vennervald, Mark Booth, et al.
Human Vaccines & Immunotherapeutics|August 8, 2023
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiencesJonathan Kitonsa, Onesmus Kamacooko, Eugene Ruzagira, et al.
Pageof 8